Tilidin
Generic name
Tilidin
Brand name
ATC Code
N02AX01
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information is present at this moment.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Severe pain |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
OPIOIDS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Natural opium alkaloids | ||
|---|---|---|
| N02AA03 | ||
| N02AA01 | ||
| N02AA05 | ||
| N02AA59 | ||
| Phenylpiperidine derivatives | ||
|---|---|---|
| N02AB03 | ||
| N02AB03 | ||
| N02AB02 | ||
| Diphenylpropylamine derivatives | ||
|---|---|---|
| N02AC06 | ||
| N02AC03 | ||
| Oripavine derivatives | ||
|---|---|---|
| N02AE01 | ||
| Morphinan derivatives | ||
|---|---|---|
| N02AF02 | ||
| Other opioids | ||
|---|---|---|
| N02AX06 | ||
| N02AX02 | ||
| Opioids in combination with non-opioid analgesics | ||
|---|---|---|
| N02AJ13 | ||
Reference
- Pfizer Pharma PFE GmbH, SmPC Valoron N, Tropfen zum Einnehmen, Lösung (16.00.00), 08/2020
Changes
Therapeutic Drug Monitoring
Overdose
